| __timestamp | TG Therapeutics, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 9804000 |
| Thursday, January 1, 2015 | 43445817 | 12796000 |
| Friday, January 1, 2016 | 66489820 | 15324000 |
| Sunday, January 1, 2017 | 96886134 | 13881000 |
| Monday, January 1, 2018 | 153793000 | 14820000 |
| Tuesday, January 1, 2019 | 148369000 | 14851000 |
| Wednesday, January 1, 2020 | 151934000 | 17204000 |
| Friday, January 1, 2021 | 198532000 | 29843000 |
| Saturday, January 1, 2022 | 112128000 | 40603000 |
| Sunday, January 1, 2023 | 76192000 | 57305000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, TG Therapeutics, Inc. and Veracyte, Inc. have demonstrated distinct strategies in their R&D allocations. TG Therapeutics has consistently outpaced Veracyte, with its R&D expenses peaking in 2021 at nearly 200% more than its 2014 levels. In contrast, Veracyte's R&D spending has shown a steady increase, culminating in a 484% rise by 2023 compared to 2014. This divergence highlights TG Therapeutics' aggressive investment in innovation, while Veracyte's gradual increase suggests a more measured approach. As the biotech sector continues to evolve, these spending patterns may offer insights into each company's strategic priorities and potential market positioning.
R&D Insights: How Pfizer Inc. and TG Therapeutics, Inc. Allocate Funds
R&D Insights: How Bristol-Myers Squibb Company and TG Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Gilead Sciences, Inc. vs TG Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Veracyte, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: argenx SE vs Veracyte, Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Veracyte, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
TG Therapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?
Comparing Innovation Spending: TG Therapeutics, Inc. and Novavax, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Veracyte, Inc.
R&D Spending Showdown: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Viridian Therapeutics, Inc.